Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation

INTRODUCTION: Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of care for metastatic melanoma patients with BRAF V600, while chemotherapy continued to be widely used in BRAF wild type patients. MATERIALS AND METHODS: In order to discover novel candidate biomarkers predictiv...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Garrisi, Vito Michele, Strippoli, Sabino, De Summa, Simona, Pinto, Rosamaria, Perrone, Antonella, Guida, Gabriella, Azzariti, Amalia, Guida, Michele, Stefania, Tommasi
Format: Artigo
Language:Inglês
Published: Public Library of Science 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249853/
https://ncbi.nlm.nih.gov/pubmed/25437182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0112025
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items